000 01130 a2200313 4500
005 20250515154151.0
264 0 _c20090206
008 200902s 0 0 eng d
022 _a1365-2044
024 7 _a10.1111/j.1365-2044.2008.05840_1.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHudson, P C
245 0 0 _aRemifentanil for fibre-optic intubation: dose considerations.
_h[electronic resource]
260 _bAnaesthesia
_cFeb 2009
300 _a221; author reply 221-2 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aConscious Sedation
_xmethods
650 0 4 _aDrug Administration Schedule
650 0 4 _aFiber Optic Technology
650 0 4 _aHumans
650 0 4 _aHypnotics and Sedatives
_xadministration & dosage
650 0 4 _aIntubation, Intratracheal
_xmethods
650 0 4 _aPiperidines
_xadministration & dosage
650 0 4 _aRemifentanil
700 1 _aNorman, A T
700 1 _aFreeman, D J
773 0 _tAnaesthesia
_gvol. 64
_gno. 2
_gp. 221; author reply 221-2
856 4 0 _uhttps://doi.org/10.1111/j.1365-2044.2008.05840_1.x
_zAvailable from publisher's website
999 _c18591588
_d18591588